MENU
+Compare
OMGAQ
Stock ticker: OTC
AS OF
Jul 11 closing price
Price
$0.07
Change
-$0.02 (-22.22%)
Capitalization
3.6M

OMGAQ Omega Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers... Show more

OMGAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OMGAQ with price predictions
Jul 11, 2025

OMGAQ in upward trend: price rose above 50-day moving average on July 03, 2025

OMGAQ moved above its 50-day moving average on July 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on OMGAQ as a result. In of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMGAQ just turned positive on June 26, 2025. Looking at past instances where OMGAQ's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for OMGAQ crossed bullishly above the 50-day moving average on July 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +10 3-day Advance, the price is estimated to grow further. Considering data from situations where OMGAQ advanced for three days, in of 172 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OMGAQ moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where OMGAQ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMGAQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OMGAQ broke above its upper Bollinger Band on July 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OMGAQ entered a downward trend on June 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.312) is normal, around the industry mean (17.292). P/E Ratio (0.000) is within average values for comparable stocks, (58.926). OMGAQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.456). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.444) is also within normal values, averaging (271.367).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OMGAQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMGAQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OMGAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OMGAQ is expected to report earnings to fall 13.33% to -25 cents per share on May 30

Omega Therapeutics, Inc. OMGAQ Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Missed
by $0.07
The last earnings report on March 31 showed earnings per share of -30 cents, missing the estimate of -22 cents. With 715.29K shares outstanding, the current market capitalization sits at 3.60M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMA2.99-0.01
-0.33%
SigmaTron International
VICI33.42-0.21
-0.62%
VICI Properties
MAN44.09-0.83
-1.85%
ManpowerGroup
BFC119.98-3.02
-2.46%
Bank First Corp
BCBP8.86-0.24
-2.64%
BCB Bancorp